These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8983365)

  • 1. [Long term survival in an HIV-immunosuppressed patient treated with foscarnet].
    Soriano V; Mas A; Bravo R; Moreno V; González-Lahoz J
    An Med Interna; 1996 Aug; 13(8):387-9. PubMed ID: 8983365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convenient twice daily foscarnet in induction therapy of AIDS-associated cytomegalovirus retinitis. The Foscarnet Italian Study Group.
    Carosi G; Castelli F; Lernestedt JO; Antoniazzi E; Gerna G
    AIDS; 1997 Feb; 11(2):258-60. PubMed ID: 9030380
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
    Mallolas J; Gatell JM; Gómez-Sirvent JL; Buira E; Zamora L; Alecrim-Andrade J; Adán A; Morales M; Miró JM; Lonća M; Guelar A; Soriano E
    Enferm Infecc Microbiol Clin; 1997 Feb; 15(2):61-4. PubMed ID: 9101748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of ganciclovir-resistant cytomegalovirus retinitis in HIV infection in the era of antiretroviral therapy.
    Adler H; De Gascun CF; McSweeney F; Acheson RW; Brannigan ET; Duffy M; Keegan DJ; Lambert JS
    Int J STD AIDS; 2014 Oct; 25(11):827-9. PubMed ID: 24516078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed.
    AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828
    [No Abstract]   [Full Text] [Related]  

  • 6. New treatment options for CMV retinitis in AIDS.
    Lalezari JP
    Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
    [No Abstract]   [Full Text] [Related]  

  • 7. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
    Labetoulle M; Goujard C; Frau E; Rogier H; Niessen F; Rudent A; Lantz O; Lecointe D; Furlan V; Delfraissy JF; Offret H
    J Fr Ophtalmol; 1998 Oct; 21(8):567-76. PubMed ID: 9833222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
    Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR
    AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA notifications. FDA approves generic foscarnet sodium injection.
    AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16110563
    [No Abstract]   [Full Text] [Related]  

  • 12. Foscavir receives new indication.
    AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMV after HAART.
    Posit Aware; 1998; 9(5):18, 23. PubMed ID: 11365888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A brighter future for the AIDS patient.
    Lowell E; Van Tassell B
    Insight; 2002; 27(4):95-6. PubMed ID: 12520982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract]   [Full Text] [Related]  

  • 16. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR; Baldassano VF; Whitcup SM
    Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and treatment of cytomegalovirus retinitis in patients with AIDS.
    Speyrer MP
    J Am Acad Nurse Pract; 1997 Jul; 9(7):329-31. PubMed ID: 9274255
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
    Weinberg A; Jabs DA; Chou S; Martin BK; Lurain NS; Forman MS; Crumpacker C; ;
    J Infect Dis; 2003 Mar; 187(5):777-84. PubMed ID: 12599051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the edge: measuring CMV viral load.
    McGuire S
    Posit Aware; 1997; 8(1):16-7. PubMed ID: 11364091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
    Ciulla TA; Rutledge BK; Morley MG; Duker JS
    Ophthalmic Surg Lasers; 1998 Mar; 29(3):198-206. PubMed ID: 9547773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.